Skip to content

A Study of Optical Fusion Trans-Perineal Grid

Optical Fusion Trans-Perineal Grid

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05573048
Enrollment
20
Registered
2022-10-10
Start date
2022-10-04
Completion date
2026-12-31
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Biopsy

Keywords

Prostate Ablation Procedure

Brief summary

The purpose of this research is to evaluate a new needle guide grid utilizing Clear Guide SCENERGY - MR with a grid embedded with VisiMARKER II to autoregister and target the prostate aiding in needle placement positioning. The proceduralist can utilize this technology to find the best needle path to target within the pelvis.

Interventions

DEVICETrans-Perineal Grid

A small square piece of plastic with many holes in it placed between the legs to help guide the path of the interventional instruments and to facilitate the prostate intervention. The guide grid will help with needle placement using the grid technology.

Sponsors

Clear Guide Medical Inc.
CollaboratorUNKNOWN
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for a MR guided biopsy or ablation. * One, two, or three tumor suspicious regions identified on multiparametric MRI. * Tolerance for anesthesia/sedation. * Ability to give informed consent.

Exclusion criteria

* Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI. * History of other primary non-skin malignancy within previous three years.

Design outcomes

Primary

MeasureTime frameDescription
Needle placement accuracyBaselineNumber of needle placements to successfully match target and needle tip position assessed by direct MR imaging and

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026